Retail segment

Russian Federation pharmacy chains rating based on the results of the 1st half of 2017

29 August 2017г.

According to the results of the first half of 2017, the number of pharmacies in Russia reached 61,812, the total turnover from the sale of the goods through the pharmacy segment amounted to 551.2 billion rubles. The three leading players (Rigla, Group 36.6, and Implozia) accumulate one tenth of the entire pharmacy market volume under their control, while the Top10 earn more than one fourth in value through less than one fifth of the total number of pharmacy outlets. 

Подробнее

Review of the market of medicinal products for the treatment of bronchial asthma and COPD based on the results of 2016

28 July 2017г.

The volume of the market for the medicinal products treating BA and COPD reached 17.8 billion by value and 44 million by volume in 2016, with a slight increase in sales compared to the previous period. People mostly purchase such medicinal product in the retail pharmacy segment, accounting for more than 70% by volume and more than 50% by value. 

Подробнее

Rating of pharmacy chains in the Russian Federation based on the results of the first quarter of 2017

29 May 2017г.

Based on the results of the first quarter of 2017, the number of pharmacies in Russia reached 60,422. Their total turnover, including all categories of goods sold through the pharmacy segment, amounted to 281.56 billion rubles. 

Подробнее

REVIEW OF THE MARKET OF MEDICINAL PRODUCTS FOR THE TREATMENT OF RESPIRATORY DISEASES WITH IMMUNOMODULATORY AND/OR ANTIVIRAL EFFECT IN THE RETAIL COMMERCIAL SECTOR OF THE PHARMACEUTICAL MARKET BASED ON THE RESULTS OF 2016

15 March 2017г.

Based on the results of 2016, the available retail commercial market for the products with immunomodulatory and/or antiviral effect [1] used for prevention and treatment of respiratory diseases reached 31.82 billion rubles [2] by value and 98.61 million packages by volume, showing a solid increase in sales of 21 and 12% respectively 

Подробнее

OVERVIEW OF THE MARKET OF SLEEP NORMALIZING PRODUCTS IN THE RETAIL COMMERCIAL SECTOR OF THE PHARMACEUTICAL MARKET, BASED ON THE RESULTS OF 2016

20 February 2017г.

Despite the prevalence of sleep problems (28 to 45% of the population), the sleep normalizing drugs are difficult to access. The access is restricted mainly because most of them are only available on prescription. Some brands are on strict record keeping in pharmacies, as controlled substances. By the results of 2016, the sales of the sleeping pills reached 1.94 billion rubles (5.24 million packages), whereas the sales of the group of other sleep improving products were 6 times more in value (12.91 billion rubles) and almost 40 times more in packages (199,14 billion packages).

Подробнее

Pages